← All indications
Varicose Ulcer
Skin breakdown or ulceration in the drainage area of a VARICOSE VEIN, usually in the leg.
Drugs by status
Approved for this indication (2)
Phase 4 trials (3)
Phase 3 trials (7)
Phase 2 trials (9)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (17)
- Smith & Nephew
- Factor Therapeutics Ltd.
- MacroCure Ltd.
- Healthpoint
- RenovoRx
- McMaster University
- St. Luke's-Roosevelt Hospital Center
- University of Manchester
- University of Miami
- University of Auckland
- University of Freiburg
- University of the Witwatersrand
- Barry University
- University of North Carolina at Chapel Hill
- Universidad Autonoma de San Luis Potosi
- Canadian Institutes of Health Research (CIHR)
- Health Research Council, New Zealand
Organization Involved with Phase 2 Indications (40)
- Energenesis Biomedical Co., Ltd.
- FGK Clinical Research GmbH
- Kringle Pharma, Inc.
- Leadiant Biosciences, Inc.
- MediWound Ltd
- Nitric BioTherapeutics, Inc
- Parexel
- RegeneRx Biopharmaceuticals, Inc.
- Rheacell GmbH & Co. KG
- SerenaGroup, Inc.
- Skingenix, Inc.
- Tissue Tech Inc.
- Ilkos Therapeutic Inc.
- Turning Point Therapeutics
- University of Pennsylvania
- Atlantic Health System
- University of London
- Newcastle University
- Sykehuset Innlandet HF
- Tower Outpatient Surgical Center
- University of Hull
- University of Leeds
- University of Nottingham
- University of Bonn
- University of York
- Cardiff University
- Tower Multispecialty Medical Group
- Osakidetza
- Istituto Dermopatico dell'Immacolata, Roma
- HCA Retreat Hospital
- +10 more
Organization Involved with Phase 1 Indications (10)
- Venturis Therapeutics
- FirstString Research, Inc.
- HealOr
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Hospital de Clínicas Dr. Manuel Quintela
- Southwest Regional Wound Care Center
- Medical University of South Carolina
- Hebrew University
- Warren General Hospital
- Spartanburg Regional Healthcare System
Organization Involved with Other Experimental Indications (7)